Fetomaternal outcomes in Oligohydramnios during Second and Third Trimester of Pregnancy
DOI:
https://doi.org/10.70749/ijbr.v3i4.2109Keywords:
Oligohydramnios, Fetomaternal Outcomes, Intrauterine Fetal Death, Prematurity, Neonatal Complications.Abstract
Background: Oligohydramnios, or decreased amniotic fluid index, has been linked with an entire continuum of poor outcomes in pregnancy. Early identification and management are very important, since it also places the mother and fetus at higher risks. It has been strongly associated with fetal compromise, abnormal presentations, premature delivery, and adverse neonatal outcomes. Objective: To determine the frequency of fetomaternal outcomes in oligohydramnios during second and third trimester of pregnancy. Study Design: Descriptive Cross-Sectional study. Duration and Place of Study: The study was conducted from January 2024 to June 2024 in the Department of Obstetrics and Gynaecology, Lady Reading Hospital, Peshawar. Methodology: A total of 101 women aged 18–40 years with singleton pregnancies beyond 13 weeks and diagnosed with oligohydramnios (amniotic fluid index ≤5 cm) were enrolled through consecutive sampling. Women with systemic disorders were excluded. Demographic and clinical details were documented, and patients were followed until delivery. Fetomaternal outcomes included caesarean section, fetal distress, malpresentation, fetal structural anomalies, intrauterine fetal death, prematurity, meconium aspiration syndrome, low birth weight, respiratory distress, early neonatal death, and need for neonatal intensive care. Results: The mean maternal age was 29.99±6.85 years and mean gestational age 26.72±7.28 weeks. Caesarean section occurred in 44.6% of cases, prematurity in 15.8%, and intrauterine fetal death in 7.9%. Neonatal complications included low birth weight (38.6%), respiratory distress (30.7%), NICU admission (32.7%), and meconium aspiration (11.9%). Conclusion: Oligohydramnios is strongly associated with adverse fetomaternal outcomes, underscoring the importance of close monitoring and timely intervention to improve prognosis.
Downloads
References
1. Huri, M., Di Tommaso, M., & Seravalli, V. (2023). Amniotic fluid disorders: From prenatal management to neonatal outcomes. Children, 10(3), 561.
https://doi.org/10.3390/children10030561
2. Shorey-Kendrick, L. E., Crosland, B. A., Spindel, E. R., McEvoy, C. T., Wilmarth, P. A., Reddy, A. P., Zientek, K. D., Roberts, V. H., D’Mello, R. J., Ryan, K. S., Olyaei, A. F., Hagen, O. L., Drake, M. G., McCarty, O. J., Scottoline, B. P., & Lo, J. O. (2023). The amniotic fluid proteome changes across gestation in humans and rhesus macaques. Scientific Reports, 13(1).
https://doi.org/10.1038/s41598-023-44855-4
3. Galaz, J., Romero, R., Slutsky, R., Xu, Y., Motomura, K., Para, R., Pacora, P., Panaitescu, B., Hsu, C., Kacerovsky, M., & Gomez-Lopez, N. (2020). Cellular immune responses in amniotic fluid of women with preterm prelabor rupture of membranes. Journal of Perinatal Medicine, 48(3), 222-233.
https://doi.org/10.1515/jpm-2019-0395
4. Wax, J. R., & Pinette, M. G. (2022). The amniotic fluid index and oligohydramnios: A deeper dive into the shallow end. American Journal of Obstetrics and Gynecology, 227(3), 462-470.
https://doi.org/10.1016/j.ajog.2022.04.016
5. Hansen, S., Kujabi, M. L., Maimburg, R. D., Macha, A., Maembe, L., Kabanda, I., Hudson, M., Msumi, R. J., Sangalala, M., Housseine, N., D'mello, B. S., Hussein, K., Akker, T. V., Meyrowitsch, D. W., & Maaløe, N. (2025). Disclosing possible nonmedically indicated cesarean sections in 5 high-volume urban maternity units in Tanzania: A criterion-based clinical audit. AJOG Global Reports, 5(1), 100437.
https://doi.org/10.1016/j.xagr.2024.100437
6. Gallo, D. M., Romero, R., Bosco, M., Gotsch, F., Jaiman, S., Jung, E., Suksai, M., Ramón y Cajal, C. L., Yoon, B. H., & Chaiworapongsa, T. (2023). Meconium-stained amniotic fluid. American Journal of Obstetrics and Gynecology, 228(5), S1158-S1178.
https://doi.org/10.1016/j.ajog.2022.11.1283
7. Amgalan, A., Kapse, K., Krishnamurthy, D., Andersen, N. R., Izem, R., Baschat, A., Quistorff, J., Gimovsky, A. C., Ahmadzia, H. K., Limperopoulos, C., & Andescavage, N. N. (2022). Measuring intrauterine growth in healthy pregnancies using quantitative magnetic resonance imaging. Journal of Perinatology, 42(7), 860-865.
https://doi.org/10.1038/s41372-022-01340-6
8. Peppiatt, I., Retrouvey, M., & Conran, R. M. (2024). Educational case: Neonatal respiratory distress syndrome. Academic Pathology, 11(2), 100115.
https://doi.org/10.1016/j.acpath.2024.100115
9. Jung, E., Romero, R., Yeo, L., Diaz-Primera, R., Marin-Concha, J., Para, R., Lopez, A. M., Pacora, P., Gomez-Lopez, N., Yoon, B. H., Kim, C. J., Berry, S. M., & Hsu, C. (2020). The fetal inflammatory response syndrome: The origins of a concept, pathophysiology, diagnosis, and obstetrical implications. Seminars in Fetal and Neonatal Medicine, 25(4), 101146.
https://doi.org/10.1016/j.siny.2020.101146
10. Leytes, S., Kovo, M., Weiner, E., & Ganer Herman, H. (2022). Isolated oligohydramnios in previous pregnancy is a risk factor for a placental related disorder in subsequent delivery. BMC Pregnancy and Childbirth, 22(1).
https://doi.org/10.1186/s12884-022-05230-9
11. Dutta, I., Suman, S., & Pan, T. (2025). Maternal and Fetal Outcomes in Idiopathic Oligohydramnios vs. Normal Amniotic Fluid Index After 34 Weeks: A Case-Control Study in Eastern India. PubMed, 66(2), 637–645.
https://doi.org/10.71480/nmj.v66i2.785
12. Talesara, H., Shah, V. C., Modi, D. A., & Modi, R. S. (2021). Fetomaternal outcome in pregnancy with oligohydramnios: A prospective study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 10(2), 571.
https://doi.org/10.18203/2320-1770.ijrcog20210305
13. Alam, K., Rizwan, A., Hussain, A. I., Farooq, S., Iftikhar, T., & Mehdi, M. (2023). The Fetomaternal outcome of induction of labour in idiopathic Oligohydramnios. Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University, 19(3), 351-355.
https://doi.org/10.48036/apims.v19i3.927
14. Sultana, M., Batool, A., Sher, Z., Hanfi, R., Kashif, S., & Haroon, H. (2025). Fetomaternal Outcomes of Borderline Oligohydramnios during the Third Trimester at a Specialized Medical Facility. Pakistan Journal of Medical Research, 64(2), 49-52.
https://pjmr.org.pk/index.php/pjmr/article/view/654
15. Vidyasagar, V., & Chutani, N. (2015). Fetomaternal outcome in cases of oligohydramnios after 28 weeks of pregnancy. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 1.
https://doi.org/10.5455/2320-1770.ijrcog20150227
16. Bashir, S. A. D. I. A., Siddiq, A. R. I. F., & Jahan, T. A. N. V. I. R. (2015). Fetomaternal outcome following diagnosis of oligohydramnios at term. Pakistan J Med Heal Sci, 9(3), 995-6.
17. Bhandari, P., Sharma, S., & Subedi, D. A. (2022). Maternal and fetal outcomes in uncomplicated postdated pregnancy. Journal of Health and Allied Sciences, 11(2), 77-81.
https://doi.org/10.37107/jhas.308
18. Solanke, R, Pallo, S, K, Rachwani, K, Dahiwade, S. (2025). Impact of oligohydramnios on the feto-maternal outcome – a retrospective study at a tertiary care center. J Popul Ther Clin Pharmacol. 2025, 32(3), 77-84.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
